Corvus Pharmaceuticals, Inc. CRVS
Corvus Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 912,722 | $13.4M | 1.14% |
| MILLENNIUM MANAGEMENT LLC | 866,362 | $12.7M | 1.09% |
| TWO SIGMA INVESTMENTS, LP | 539,869 | $7.9M | 0.68% |
| RENAISSANCE TECHNOLOGIES LLC | 81,310 | $1.2M | 0.1% |
| BlackRock Finance, Inc. | 562,024 | $1.0M | 0.7% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.